CLINICAL HIGH RISK FOR PSYCHOSIS (CHR)
Clinical trials for CLINICAL HIGH RISK FOR PSYCHOSIS (CHR) explained in plain language.
Never miss a new study
Get alerted when new CLINICAL HIGH RISK FOR PSYCHOSIS (CHR) trials appear
Sign up with your email to follow new studies for CLINICAL HIGH RISK FOR PSYCHOSIS (CHR), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Brain games may keep psychosis at bay in At-Risk youth
Symptom relief Recruiting nowThis study tests whether a 12-week computer-based cognitive training program can improve thinking skills and daily functioning in 54 Tunisian youth at clinical high risk for psychosis. Participants will either do fun brain exercises and learn thinking strategies, or receive stand…
Matched conditions: CLINICAL HIGH RISK FOR PSYCHOSIS (CHR)
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated May 17, 2026 02:07 UTC
-
Can online therapy help prevent psychosis in At-Risk youth?
Symptom relief Recruiting nowThis study tests whether group or family therapy delivered via telehealth can help young people (ages 14-25) who are at high risk for psychosis. Participants will receive one of three types of cognitive behavioral therapy (CBT) adapted for online sessions. The goal is to see if t…
Matched conditions: CLINICAL HIGH RISK FOR PSYCHOSIS (CHR)
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated May 17, 2026 02:06 UTC
-
Mindfulness under the microscope: new study probes risks and realities for Psychosis-Prone youth
Knowledge-focused Recruiting nowThis study interviews 20 people aged 15-30 who are at ultra-high risk for psychosis or have had a first episode. Researchers want to understand what it feels like to practice mindfulness in a group setting, including any negative effects. The goal is to learn, not to treat.
Matched conditions: CLINICAL HIGH RISK FOR PSYCHOSIS (CHR)
Phase: NA • Sponsor: Centre Psychothérapique de Nancy • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
New study aims to find better ways to measure early psychosis treatment effects
Knowledge-focused Recruiting nowThis study is for people aged 17 to 30 who are at high risk of developing psychosis. Researchers want to see if certain tests (like memory and symptom checklists) can detect changes after taking the study drug MT1988 twice daily for 8 weeks. The goal is to find better ways to mea…
Matched conditions: CLINICAL HIGH RISK FOR PSYCHOSIS (CHR)
Phase: PHASE1, PHASE2 • Sponsor: Monument Therapeutics Limited • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC
-
New french tool could help catch psychosis early in teens
Knowledge-focused Recruiting nowThis study aims to validate a French version of a questionnaire that helps detect very early signs of psychosis risk in teenagers. Researchers will check if different clinicians give consistent ratings when using the tool with 52 adolescents aged 12-17. The goal is to improve ear…
Matched conditions: CLINICAL HIGH RISK FOR PSYCHOSIS (CHR)
Phase: NA • Sponsor: Centre Psychothérapique de Nancy • Aim: Knowledge-focused
Last updated May 12, 2026 13:42 UTC